CanNegev is pleased to announce that Dry Powder Inhaler (DPI) has joined the CanNegev Incubator program. This follows approval by the Israel Innovation Authority (IAA).
CanDI DPI is a breakthrough in delivering medications and cannabinoids to the lungs by dry powder inhalator. Suitable for any generic and systemic medical powder drugs. Easy to use for all patients.
We wish CanDI every success!
